Psychedelics have demonstrated significant progress, generating enthusiasm across the neuroscience industry and leading to ...

Psychedelics have demonstrated significant progress, with promising data and increased interest from large companies, ...

Layoffs are looming in Switzerland as Novartis announces its plans to cut upwards of 550 full-time positions by the end of ...

Businesses want to be available to provide for employees and be competitive. They want workers to be able to go to the HR ...

Moderna secured a $1.5 billion loan from Ares Management, structured in three tranches, to support financial flexibility and ...

In today’s Pharmaceutical Executive Daily, Novo Nordisk faces market pressure after a late-stage trial setback, Moderna takes ...

Renaud Savary is Senior Investment Analyst, Pharmaceutical Sector, at Avem Capital.

Cancerguard, a multi-cancer early detection blood test.

AI and computational modeling are reducing reliance on animal testing by simulating human biology, improving drug safety and ...

Tesaro confirmed its litigation against AnaptysBio in the Delaware Chancery Court in a press release on its website, ...

In today’s Pharmaceutical Executive Daily, learn how Tesaro is suing AnaptysBio over alleged contract breaches, Flagship ...

Amid the usual hustle before a big medical conference or industry trade show, editors are often buried under a flood of news ...